4E Therapeutics

Craig Benson

 T. Craig Benson has been Founder and Executive Chairman of the Board of Directors of Beyond Batten Disease Foundation (BBDF) since October 2008.  BBDF is engaged in therapeutic development and patient advocacy for the juvenile form of Batten Disease. Its lead candidate, BBDF-101, has recently been licensed to a publicly traded pharmaceutical company for further development. From 2002-2014, Mr. Benson was CEO and President of Rules-Based Medicine, Inc. (later MyriadRBM, Inc.), a life science pharma service/diagnostic company, after directing its spin-off from Luminex Corporation (NASDAQ:LMNX). The business was acquired by Myriad Genetics (NASDAQ:MYGN) in 2011.   During 2000-2004, he also served as Chairman of the Board for Equity Resource Partners, LLC, a private investment company.  From 1987- 2000, Benson was employed by Service Corporation International (NYSE: SCI).  During his tenure with SCI, he held various senior executive management positions, which included domestic and international merger and acquisition responsibilities, Vice-President of Marketing and Corporate Alliances, as well as President of SCI International, Ltd., SCI's International holding company with over $2 billion in overseas operations. From 1990 to 1994, Benson served as President of Investment Capital Corporation, the private equity arm of SCI, which held over $350 million in assets. From 1984 to 1987, he held management positions with Pulaski Investment Corporation, a bank holding company engaged in commercial and mortgage finance activities.

Benson has been the CEO and Managing Director of Callaway Partners, LP since 2004. Callaway is engaged in various private investments in the areas of banking, specialty finance, oil and gas, and healthcare. Benson also currently serves as Senior Managing Director of Crestmoor Capital Partners. Crestmoor deploys its capital to assist bank and finance partners with problem loans and assets through its proprietary repositioning structures. Mr. Benson has served as General Partner at Caddo Minerals, Inc. since 2013, which is a private energy investment company.

Mr. Benson has served on the Board of Directors of four publicly held companies and is a member of Young Presidents Organization (YPO). Also, he is a member of the International Advisory Board of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, Texas. He received a BBA degree from Southern Methodist University in 1984.